Applications from the field of Pharma & Biopharma from Shimadzu | LabRulez ICPMS
Validation of Analysis Method Using ICPMS-2030 Based on USP <233> ELEMENTAL IMPURITIES - PROCEDURES
Applications
| 2020 | Shimadzu
ICP/MS
Instrumentation
ICP/MS
Manufacturer
Shimadzu
Industries
Pharma & Biopharma
Validation of quantitative method for determination of elemental impurities in pharmaceutical products following USP 232/233 on ICPMS-2030
Applications
| 2019 | Shimadzu
ICP/MS
Instrumentation
ICP/MS
Manufacturer
Shimadzu
Industries
Pharma & Biopharma
Prev
1
Next
Related content
V4+ Conference on Environment and Health in Central Europe
We, 8.5.2024
RECETOX - Centrum pro výzkum toxických látek v prostředí
Detecting nanoplastics – in fractions of a second
Tu, 7.5.2024
TU Wien
The U.S. Pharmacopeia (USP) and Mestrelab Research, S.L. (Mestrelab), are pleased to announce they have entered into a collaboration to deliver USP-ID, through Mestrelab’s Mnova platform.